• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间皮素表达是胆管细胞癌的一个预后因素。

Mesothelin expression is a prognostic factor in cholangiocellular carcinoma.

作者信息

Nomura Ryohei, Fujii Hiroaki, Abe Masaaki, Sugo Hiroyuki, Ishizaki Yoichi, Kawasaki Seiji, Hino Okio

机构信息

1 Department of Hepatobiliary-Pancreatic Surgery and.

出版信息

Int Surg. 2013 Apr-Jun;98(2):164-9. doi: 10.9738/INTSURG-D-13-00001.1.

DOI:10.9738/INTSURG-D-13-00001.1
PMID:23701154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3723172/
Abstract

Although mesothelin is highly expressed in epithelial mesotheliomas, and also in adenocarcinomas of the ovary and pancreas, the clinical significance of mesothelin in cholangiocellular carcinoma (CC) has not been reported, and its biologic features are largely unknown. In the present study, mesothelin expression was evaluated in 25 patients with CC using a well-characterized mesothelin monoclonal antibody (5B2). A total of 8 of the 25 patients with CC (32%) showed mesothelin immunoreactivity. The 25 patients were divided into 2 groups according to the percentage of tumor cells that were positive for mesothelin expression: negative (n = 17) or focally positive (mesothelin expression evident in less than 50%, n = 4; total, n = 21 for both groups), and positive (mesothelin expression evident in 50% or more, n = 4). The survival periods in both groups were statistically analyzed. The negative/focally positive group showed significantly longer postoperative survival than the positive group (P = 0.006). Also, mesothelin positivity was identified as an independent predictor of short postoperative survival. The present results suggest that mesothelin expression is a prognostic indicator in patients with CC.

摘要

尽管间皮素在上皮性间皮瘤中高表达,在卵巢癌和胰腺癌中也有表达,但间皮素在胆管细胞癌(CC)中的临床意义尚未见报道,其生物学特性也大多未知。在本研究中,使用一种特性明确的间皮素单克隆抗体(5B2)对25例CC患者的间皮素表达进行了评估。25例CC患者中共有8例(32%)表现出间皮素免疫反应性。根据间皮素表达阳性的肿瘤细胞百分比,将25例患者分为两组:阴性组(n = 17)或局灶阳性组(间皮素表达在50%以下明显,n = 4;两组共n = 21),以及阳性组(间皮素表达在50%或以上明显,n = 4)。对两组的生存期进行了统计学分析。阴性/局灶阳性组术后生存期明显长于阳性组(P = 0.006)。此外,间皮素阳性被确定为术后生存期短的独立预测因素。目前的结果表明,间皮素表达是CC患者的一个预后指标。

相似文献

1
Mesothelin expression is a prognostic factor in cholangiocellular carcinoma.间皮素表达是胆管细胞癌的一个预后因素。
Int Surg. 2013 Apr-Jun;98(2):164-9. doi: 10.9738/INTSURG-D-13-00001.1.
2
Impact of stroma LOXL2 overexpression on the prognosis of intrahepatic cholangiocarcinoma.基质LOXL2过表达对肝内胆管癌预后的影响
J Surg Res. 2016 Jun 15;203(2):441-50. doi: 10.1016/j.jss.2016.03.044. Epub 2016 Mar 26.
3
Prognostic evaluation of mucin-5AC expression in intrahepatic cholangiocarcinoma, mass-forming type, following hepatectomy.肝切除术后肿块型肝内胆管癌中黏蛋白-5AC表达的预后评估
Eur J Surg Oncol. 2015 Nov;41(11):1515-21. doi: 10.1016/j.ejso.2015.07.006. Epub 2015 Jul 17.
4
[Surgical treatment of cholangiocellular carcinoma and proximal bile duct tumors].胆管细胞癌及近端胆管肿瘤的外科治疗
Zentralbl Chir. 2000;125(7):637-41.
5
Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma.使用不同单克隆抗体5B2和MN-1对1562例肿瘤进行间皮素(MSLN)的全面免疫组织化学研究,并评估其在恶性胸膜间皮瘤中的预后价值。
Oncotarget. 2017 Apr 18;8(16):26744-26754. doi: 10.18632/oncotarget.15814.
6
Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.比较胆道癌患者手术后基于炎症的预后评分。
Anticancer Res. 2021 Apr;41(4):2147-2155. doi: 10.21873/anticanres.14987.
7
Clinical and pathological features of Allen's type C classification of resected combined hepatocellular and cholangiocarcinoma: a comparative study with hepatocellular carcinoma and cholangiocellular carcinoma.切除的肝细胞癌合并胆管癌的艾伦C型分类的临床和病理特征:与肝细胞癌和胆管细胞癌的比较研究
J Gastrointest Surg. 2006 Jul-Aug;10(7):987-98. doi: 10.1016/j.gassur.2006.01.018.
8
[Cholangiocellular carcinoma--clinical features and surgical treatment].胆管细胞癌——临床特征与外科治疗
Khirurgiia (Sofiia). 2004;60(6):5-7.
9
Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma.鉴定肝癌衍生生长因子作为一种潜在的肝外胆管癌的预后和诊断标志物。
World J Surg. 2013 Oct;37(10):2419-27. doi: 10.1007/s00268-013-2132-4.
10
Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancer.间皮素的细胞内定位可预测肝外胆管癌患者的预后。
Int J Oncol. 2012 Dec;41(6):2109-18. doi: 10.3892/ijo.2012.1662. Epub 2012 Oct 15.

引用本文的文献

1
Advancing Cholangiocarcinoma Care: Insights and Innovations in T Cell Therapy.推进胆管癌治疗:T细胞疗法的见解与创新
Cancers (Basel). 2024 Sep 23;16(18):3232. doi: 10.3390/cancers16183232.
2
Application of CAR-T cell therapy targeting mesothelin in solid tumor treatment.靶向间皮素的嵌合抗原受体T细胞疗法在实体瘤治疗中的应用。
Discov Oncol. 2024 Jul 18;15(1):289. doi: 10.1007/s12672-024-01159-x.
3
Biology of Mesothelin and Clinical Implications: A Review of Existing Literature.间皮素生物学及其临床意义:现有文献综述
World J Oncol. 2023 Oct;14(5):340-349. doi: 10.14740/wjon1655. Epub 2023 Sep 20.
4
High Mesothelin expression in pancreatic adenocarcinoma is associated with aggressive tumor features but not prognosis.间皮素在胰腺腺癌中的高表达与侵袭性肿瘤特征相关,但与预后无关。
Am J Cancer Res. 2023 Sep 15;13(9):4235-4245. eCollection 2023.
5
Challenges of Anti-Mesothelin CAR-T-Cell Therapy.抗间皮素嵌合抗原受体T细胞疗法面临的挑战
Cancers (Basel). 2023 Feb 21;15(5):1357. doi: 10.3390/cancers15051357.
6
High mesothelin expression is correlated with non-squamous cell histology and poor survival in cervical cancer: a retrospective study.高间皮素表达与宫颈癌非鳞状细胞组织学和不良预后相关:一项回顾性研究。
BMC Cancer. 2022 Nov 24;22(1):1215. doi: 10.1186/s12885-022-10277-0.
7
Eradicating mesothelin-positive human gastric and pancreatic tumors in xenograft models with optimized anti-mesothelin antibody-drug conjugates from synthetic antibody libraries.利用合成抗体文库优化的抗间皮素抗体-药物偶联物消除异种移植模型中的间皮素阳性人胃和胰腺肿瘤。
Sci Rep. 2021 Jul 29;11(1):15430. doi: 10.1038/s41598-021-94902-1.
8
Significant Response to Camrelizumab Plus Targeted Drugs in Recurrent Intrahepatic Cholangiocarcinoma: a Case Report and Literature Review.卡瑞利珠单抗联合靶向药物治疗复发型肝内胆管细胞癌:一例病例报告及文献复习。
J Gastrointest Cancer. 2022 Sep;53(3):817-824. doi: 10.1007/s12029-021-00637-7. Epub 2021 Jul 26.
9
Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors.间皮素在人类肿瘤中的表达:一项针对12679例肿瘤的组织芯片研究。
Biomedicines. 2021 Apr 7;9(4):397. doi: 10.3390/biomedicines9040397.
10
Different role of MSLN and CA125 co-expression as a prognostic predictor between perihilar and distal bile duct carcinoma.MSLN和CA125共表达在肝门部胆管癌和远端胆管癌中作为预后预测指标的不同作用。
Oncol Lett. 2021 May;21(5):414. doi: 10.3892/ol.2021.12675. Epub 2021 Mar 23.

本文引用的文献

1
Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer.间皮素是胰腺癌的一种恶性因子和治疗性疫苗靶点。
Mol Cancer Ther. 2008 Feb;7(2):286-96. doi: 10.1158/1535-7163.MCT-07-0483.
2
High cancer-specific expression of mesothelin (MSLN) is attributable to an upstream enhancer containing a transcription enhancer factor dependent MCAT motif.间皮素(MSLN)的高癌症特异性表达归因于一个上游增强子,该增强子含有一个依赖转录增强因子的MCAT基序。
Cancer Res. 2007 Oct 1;67(19):9055-65. doi: 10.1158/0008-5472.CAN-07-0474.
3
Mesothelin, a possible target for immunotherapy, is expressed in primary AML cells.间皮素是免疫治疗的一个可能靶点,在原发性急性髓系白血病(AML)细胞中表达。
Eur J Haematol. 2007 Oct;79(4):281-6. doi: 10.1111/j.1600-0609.2007.00928.x. Epub 2007 Sep 4.
4
Overexpression of folate binding protein and mesothelin are associated with uterine serous carcinoma.叶酸结合蛋白和间皮素的过表达与子宫浆液性癌相关。
Gynecol Oncol. 2007 Jun;105(3):563-70. doi: 10.1016/j.ygyno.2006.10.063. Epub 2007 Apr 2.
5
Mesothelin expression in human lung cancer.间皮素在人类肺癌中的表达。
Clin Cancer Res. 2007 Mar 1;13(5):1571-5. doi: 10.1158/1078-0432.CCR-06-2161.
6
Diffuse mesothelin expression correlates with prolonged patient survival in ovarian serous carcinoma.弥漫性间皮素表达与卵巢浆液性癌患者的生存期延长相关。
Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):827-31. doi: 10.1158/1078-0432.CCR-05-1397.
7
Mesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitis.间皮素在胰胆管腺癌中过表达,但在正常胰腺和慢性胰腺炎中不表达。
Am J Clin Pathol. 2005 Dec;124(6):838-45.
8
Expression of mesothelin mRNA in pure pancreatic juice from patients with pancreatic carcinoma, intraductal papillary mucinous neoplasm of the pancreas, and chronic pancreatitis.间皮素mRNA在胰腺癌、胰腺导管内乳头状黏液性肿瘤及慢性胰腺炎患者纯胰液中的表达。
Pancreas. 2005 May;30(4):349-54. doi: 10.1097/01.mpa.0000160281.56828.76.
9
Mesothelin: a new target for immunotherapy.间皮素:免疫疗法的新靶点。
Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):3937-42. doi: 10.1158/1078-0432.CCR-03-0801.
10
Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.胰腺导管腺癌中的高表达基因:对通过三种主要技术获得的转录谱的全面表征与比较
Cancer Res. 2003 Dec 15;63(24):8614-22.